Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Robert Ryu to Aged

This is a "connection" page, showing publications Robert Ryu has written about Aged.

 
Connection Strength
  
 
 
0.577
  
  1. Trivedi PS, Lind KE, Ray CE, Rochon PJ, Ryu RK. Race and Sex Disparities in Outcomes of Dialysis Access Maintenance Interventions. J Vasc Interv Radiol. 2018 04; 29(4):476-481.e1.
    View in: PubMed
    Score: 0.043
  2. Trivedi PS, Rochon PJ, Durham JD, Ryu RK. National Trends and Outcomes of Transjugular Intrahepatic Portosystemic Shunt Creation Using the Nationwide Inpatient Sample. J Vasc Interv Radiol. 2016 Jun; 27(6):838-45.
    View in: PubMed
    Score: 0.037
  3. Gipson MG, Smith MT, Durham JD, Brown A, Johnson T, Ray CE, Gupta RK, Kondo KL, Rochon PJ, Ryu RK. Intravascular US-Guided Portal Vein Access: Improved Procedural Metrics during TIPS Creation. J Vasc Interv Radiol. 2016 Aug; 27(8):1140-7.
    View in: PubMed
    Score: 0.037
  4. Desai KR, Lewandowski RJ, Salem R, Mouli SK, Karp JK, Laws JL, Ryu RK. Retrieval of Inferior Vena Cava Filters With Prolonged Dwell Time: A Single-Center Experience in 648 Retrieval Procedures. JAMA Intern Med. 2015 Sep; 175(9):1572-4.
    View in: PubMed
    Score: 0.036
  5. Ryu RK, Desai K, Karp J, Gupta R, Evans AE, Rajeswaran S, Salem R, Lewandowski RJ. A Comparison of Retrievability: Celect versus Option Filter. J Vasc Interv Radiol. 2015 Jun; 26(6):865-9.
    View in: PubMed
    Score: 0.035
  6. Oppenheimer JD, Kasuganti D, Nayar R, Chrisman HB, Lewandowski RJ, Nemcek AA, Ryu RK. How to interpret thyroid biopsy results: a three-year retrospective interventional radiology experience. Cardiovasc Intervent Radiol. 2010 Aug; 33(4):800-5.
    View in: PubMed
    Score: 0.024
  7. Timperman PE, Sichlau M, Ryu RK. Greater energy delivery improves treatment success of endovenous laser treatment of incompetent saphenous veins. J Vasc Interv Radiol. 2004 Oct; 15(10):1061-3.
    View in: PubMed
    Score: 0.017
  8. Wadhwa V, Gutta NB, Trivedi PS, Chatterjee K, Ahmed O, Ryu RK, Kalva SP. In-Hospital Mortality Benefit of Inferior Vena Cava Filters in Patients With Pulmonary Embolism and Congestive Heart Failure. AJR Am J Roentgenol. 2018 09; 211(3):672-676.
    View in: PubMed
    Score: 0.011
  9. Holly BP, Gaba RC, Lessne ML, Lewandowski RJ, Ryu RK, Desai KR, Sing RF. Vena Cava Filter Retrieval with Aorto-Iliac Arterial Strut Penetration. Cardiovasc Intervent Radiol. 2018 Aug; 41(8):1184-1188.
    View in: PubMed
    Score: 0.011
  10. Ryu R, Lin TC, Kumpe D, Krysl J, Durham JD, Goff JS, Everson GT, Kam I, Wachs M, Russ P, Shrestha R, Trouillot TE, Bilir BM. Percutaneous mesenteric venous thrombectomy and thrombolysis: successful treatment followed by liver transplantation. Liver Transpl Surg. 1998 May; 4(3):222-5.
    View in: PubMed
    Score: 0.011
  11. Ryu RK, Durham JD, Kumpe DA. Transcatheter venous thrombolysis--pitfalls and pratfalls: a case discussion of indications, technique, and alternatives. J Vasc Interv Radiol. 1997 Nov-Dec; 8(6):1005-10.
    View in: PubMed
    Score: 0.010
  12. Desai KR, Laws JL, Salem R, Mouli SK, Errea MF, Karp JK, Yang Y, Ryu RK, Lewandowski RJ. Defining Prolonged Dwell Time: When Are Advanced Inferior Vena Cava Filter Retrieval Techniques Necessary? An Analysis in 762 Procedures. Circ Cardiovasc Interv. 2017 Jun; 10(6).
    View in: PubMed
    Score: 0.010
  13. Yoon DY, Vavra AK, Eifler AC, Teter K, Eskandari MK, Ryu RK, Rodriguez HE. Why Temporary Filters Are Not Removed: Clinical Predictors in 1,000 Consecutive Cases. Ann Vasc Surg. 2017 Jul; 42:64-70.
    View in: PubMed
    Score: 0.010
  14. Salem R, Vouche M, Baker T, Herrero JI, Caicedo JC, Fryer J, Hickey R, Habib A, Abecassis M, Koller F, Vogelzang R, Desai K, Thornburg B, Hohlastos E, Resnick S, Lewandowski RJ, Sato K, Ryu RK, Ganger D, Kulik L. Pretransplant Portal Vein Recanalization-Transjugular Intrahepatic Portosystemic Shunt in Patients With Complete Obliterative Portal Vein Thrombosis. Transplantation. 2015 Nov; 99(11):2347-55.
    View in: PubMed
    Score: 0.009
  15. Gordon AC, Gradishar WJ, Kaklamani VG, Thuluvath AJ, Ryu RK, Sato KT, Gates VL, Salem R, Lewandowski RJ. Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy. J Vasc Interv Radiol. 2014 Oct; 25(10):1523-32, 1532.e1-2.
    View in: PubMed
    Score: 0.008
  16. Wang D, Gaba RC, Jin B, Lewandowski RJ, Riaz A, Memon K, Ryu RK, Sato KT, Kulik LM, Mulcahy MF, Larson AC, Salem R, Omary RA. Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology. 2014 Aug; 272(2):587-97.
    View in: PubMed
    Score: 0.008
  17. Memon K, Kulik LM, Lewandowski RJ, Wang E, Wang J, Ryu RK, Hickey R, Vouche M, Baker T, Ganger D, Gates VL, Habib A, Mulcahy MF, Salem R. Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization. J Vasc Interv Radiol. 2014 Jul; 25(7):1056-66.
    View in: PubMed
    Score: 0.008
  18. Lewandowski RJ, Minocha J, Memon K, Riaz A, Gates VL, Ryu RK, Sato KT, Omary R, Salem R. Sustained safety and efficacy of extended-shelf-life (90)Y glass microspheres: long-term follow-up in a 134-patient cohort. Eur J Nucl Med Mol Imaging. 2014 Mar; 41(3):486-93.
    View in: PubMed
    Score: 0.008
  19. Vouche M, Lewandowski RJ, Atassi R, Memon K, Gates VL, Ryu RK, Gaba RC, Mulcahy MF, Baker T, Sato K, Hickey R, Ganger D, Riaz A, Fryer J, Caicedo JC, Abecassis M, Kulik L, Salem R. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol. 2013 Nov; 59(5):1029-36.
    View in: PubMed
    Score: 0.008
  20. Mouli S, Memon K, Baker T, Benson AB, Mulcahy MF, Gupta R, Ryu RK, Salem R, Lewandowski RJ. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol. 2013 Aug; 24(8):1227-34.
    View in: PubMed
    Score: 0.008
  21. Memon K, Kulik L, Lewandowski RJ, Gupta R, Ryu RK, Miller FH, Vouche M, Atassi R, Ganger D, Mulcahy MF, Salem R. Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials. J Vasc Interv Radiol. 2013 Aug; 24(8):1189-1197.e2.
    View in: PubMed
    Score: 0.008
  22. Memon K, Kulik L, Lewandowski RJ, Wang E, Ryu RK, Riaz A, Nikolaidis P, Miller FH, Yaghmai V, Baker T, Abecassis M, Benson AB, Mulcahy MF, Omary RA, Salem R. Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysis. J Hepatol. 2012 May; 56(5):1112-1120.
    View in: PubMed
    Score: 0.007
  23. Ryu RK. Arthroscopic subacromial decompression: a clinical review. Arthroscopy. 1992; 8(2):141-7.
    View in: PubMed
    Score: 0.007
  24. Memon K, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Gates VL, Atassi B, Newman S, Omary RA, Benson AB, Salem R. Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):887-94.
    View in: PubMed
    Score: 0.007
  25. Ibrahim SM, Kulik L, Baker T, Ryu RK, Mulcahy MF, Abecassis M, Salem R, Lewandowski RJ. Treating and downstaging hepatocellular carcinoma in the caudate lobe with yttrium-90 radioembolization. Cardiovasc Intervent Radiol. 2012 Oct; 35(5):1094-101.
    View in: PubMed
    Score: 0.007
  26. Wang D, Gaba RC, Jin B, Riaz A, Lewandowski RJ, Ryu RK, Sato KT, Ragin AB, Kulik LM, Mulcahy MF, Salem R, Larson AC, Omary RA. Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma. Acad Radiol. 2011 Jul; 18(7):828-36.
    View in: PubMed
    Score: 0.007
  27. Memon K, Kulik L, Lewandowski RJ, Wang E, Riaz A, Ryu RK, Sato KT, Marshall K, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Senthilnathan S, Baker T, Gates VL, Abecassis M, Benson AB, Mulcahy MF, Omary RA, Salem R. Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times. Gastroenterology. 2011 Aug; 141(2):526-35, 535.e1-2.
    View in: PubMed
    Score: 0.007
  28. Jin B, Wang D, Lewandowski RJ, Riaz A, Ryu RK, Sato KT, Larson AC, Salem R, Omary RA. Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma. AJR Am J Roentgenol. 2011 Apr; 196(4):919-28.
    View in: PubMed
    Score: 0.007
  29. Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Ibrahim SM, Senthilnathan S, Baker T, Gates VL, Atassi B, Newman S, Memon K, Chen R, Vogelzang RL, Nemcek AA, Resnick SA, Chrisman HB, Carr J, Omary RA, Abecassis M, Benson AB, Mulcahy MF. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2011 Feb; 140(2):497-507.e2.
    View in: PubMed
    Score: 0.006
  30. Minocha J, Idakoji I, Riaz A, Karp J, Gupta R, Chrisman HB, Salem R, Ryu RK, Lewandowski RJ. Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinic. J Vasc Interv Radiol. 2010 Dec; 21(12):1847-51.
    View in: PubMed
    Score: 0.006
  31. Riaz A, Memon K, Miller FH, Nikolaidis P, Kulik LM, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Mulcahy MF, Baker T, Wang E, Gupta R, Nayar R, Benson AB, Abecassis M, Omary R, Salem R. Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation. J Hepatol. 2011 Apr; 54(4):695-704.
    View in: PubMed
    Score: 0.006
  32. Chung JC, Naik NK, Lewandowski RJ, Deng J, Mulcahy MF, Kulik LM, Sato KT, Ryu RK, Salem R, Larson AC, Omary RA. Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World J Gastroenterol. 2010 Jul 07; 16(25):3161-7.
    View in: PubMed
    Score: 0.006
  33. Gaba RC, Riaz A, Lewandowski RJ, Ibrahim SM, Ryu RK, Sato KT, Omary RA, Salem R. Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction. J Vasc Interv Radiol. 2010 Aug; 21(8):1213-8.
    View in: PubMed
    Score: 0.006
  34. Lewandowski RJ, Mulcahy MF, Kulik LM, Riaz A, Ryu RK, Baker TB, Ibrahim SM, Abecassis MI, Miller FH, Sato KT, Senthilnathan S, Resnick SA, Wang E, Gupta R, Chen R, Newman SB, Chrisman HB, Nemcek AA, Vogelzang RL, Omary RA, Benson AB, Salem R. Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology. 2010 Jun; 255(3):955-65.
    View in: PubMed
    Score: 0.006
  35. Riaz A, Gates VL, Atassi B, Lewandowski RJ, Mulcahy MF, Ryu RK, Sato KT, Baker T, Kulik L, Gupta R, Abecassis M, Benson AB, Omary R, Millender L, Kennedy A, Salem R. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):163-71.
    View in: PubMed
    Score: 0.006
  36. Riaz A, Miller FH, Kulik LM, Nikolaidis P, Yaghmai V, Lewandowski RJ, Mulcahy MF, Ryu RK, Sato KT, Gupta R, Wang E, Baker T, Abecassis M, Benson AB, Nemcek AA, Omary R, Salem R. Imaging response in the primary index lesion and clinical outcomes following transarterial locoregional therapy for hepatocellular carcinoma. JAMA. 2010 Mar 17; 303(11):1062-9.
    View in: PubMed
    Score: 0.006
  37. Duke E, Deng J, Ibrahim SM, Lewandowski RJ, Ryu RK, Sato KT, Miller FH, Kulik L, Mulcahy MF, Larson AC, Salem R, Omary RA. Agreement between competing imaging measures of response of hepatocellular carcinoma to yttrium-90 radioembolization. J Vasc Interv Radiol. 2010 Apr; 21(4):515-21.
    View in: PubMed
    Score: 0.006
  38. Yu M, Lewandowski RJ, Ibrahim S, Riaz A, Ryu RK, Benito A, Alonso-Burgos A, Bilbao JI, Salem R. Direct hepatic artery puncture for transarterial therapy in liver cancer. J Vasc Interv Radiol. 2010 Mar; 21(3):394-9.
    View in: PubMed
    Score: 0.006
  39. Riaz A, Lewandowski RJ, Kulik L, Ryu RK, Mulcahy MF, Baker T, Gates V, Nayar R, Wang E, Miller FH, Sato KT, Omary RA, Abecassis M, Salem R. Radiologic-pathologic correlation of hepatocellular carcinoma treated with chemoembolization. Cardiovasc Intervent Radiol. 2010 Dec; 33(6):1143-52.
    View in: PubMed
    Score: 0.006
  40. Dunfee BL, Riaz A, Lewandowski RJ, Ibrahim S, Mulcahy MF, Ryu RK, Atassi B, Sato KT, Newman S, Omary RA, Benson A, Salem R. Yttrium-90 radioembolization for liver malignancies: prognostic factors associated with survival. J Vasc Interv Radiol. 2010 Jan; 21(1):90-5.
    View in: PubMed
    Score: 0.006
  41. Lewandowski RJ, Riaz A, Ryu RK, Mulcahy MF, Sato KT, Kulik LM, Gates VL, Baker T, Omary R, Salem R. Optimization of radioembolic effect with extended-shelf-life yttrium-90 microspheres: results from a pilot study. J Vasc Interv Radiol. 2009 Dec; 20(12):1557-63.
    View in: PubMed
    Score: 0.006
  42. Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, Atassi B, Baker T, Gates V, Miller FH, Sato KT, Wang E, Gupta R, Benson AB, Newman SB, Omary RA, Abecassis M, Kulik L. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology. 2010 Jan; 138(1):52-64.
    View in: PubMed
    Score: 0.006
  43. Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, Ibrahim SM, Sato KT, Baker T, Miller FH, Omary R, Abecassis M, Salem R. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant. 2009 Aug; 9(8):1920-8.
    View in: PubMed
    Score: 0.006
  44. Lynch TC, Crues JV, Morgan FW, Sheehan WE, Harter LP, Ryu R. Bone abnormalities of the knee: prevalence and significance at MR imaging. Radiology. 1989 Jun; 171(3):761-6.
    View in: PubMed
    Score: 0.006
  45. Mulcahy MF, Lewandowski RJ, Ibrahim SM, Sato KT, Ryu RK, Atassi B, Newman S, Talamonti M, Omary RA, Benson A, Salem R. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer. 2009 May 01; 115(9):1849-58.
    View in: PubMed
    Score: 0.006
  46. Gaba RC, Lewandowski RJ, Kulik LM, Riaz A, Ibrahim SM, Mulcahy MF, Ryu RK, Sato KT, Gates V, Abecassis MM, Omary RA, Baker TB, Salem R. Radiation lobectomy: preliminary findings of hepatic volumetric response to lobar yttrium-90 radioembolization. Ann Surg Oncol. 2009 Jun; 16(6):1587-96.
    View in: PubMed
    Score: 0.006
  47. Riaz A, Kulik L, Lewandowski RJ, Ryu RK, Giakoumis Spear G, Mulcahy MF, Abecassis M, Baker T, Gates V, Nayar R, Miller FH, Sato KT, Omary RA, Salem R. Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology. 2009 Apr; 49(4):1185-93.
    View in: PubMed
    Score: 0.006
  48. Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, Newman SB, Benson A, Omary RA, Salem R. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer. 2008 Oct 15; 113(8):2119-28.
    View in: PubMed
    Score: 0.006
  49. Salem R, Parikh P, Atassi B, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Ibrahim S, Mulcahy MF, Kulik L, Liu DM, Riaz A, Omary RA, Kennedy AS. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol. 2008 Oct; 31(5):431-8.
    View in: PubMed
    Score: 0.006
  50. Ibrahim SM, Lewandowski RJ, Ryu RK, Sato KT, Gates VL, Mulcahy MF, Kulik L, Larson AC, Omary RA, Salem R. Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments. Cardiovasc Intervent Radiol. 2008 Nov-Dec; 31(6):1124-32.
    View in: PubMed
    Score: 0.005
  51. Lewandowski RJ, Tepper J, Wang D, Ibrahim S, Miller FH, Kulik L, Mulcahy M, Ryu RK, Sato K, Larson AC, Salem R, Omary RA. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2008 May; 19(5):698-705.
    View in: PubMed
    Score: 0.005
  52. Larson AC, Wang D, Atassi B, Sato KT, Ryu RK, Lewandowski RJ, Nemcek AA, Mulcahy MF, Kulik LM, Miller FH, Salem R, Omary RA. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation. Radiology. 2008 Mar; 246(3):964-71.
    View in: PubMed
    Score: 0.005
  53. Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson A, Nemcek AA, Gates VL, Abecassis M, Omary RA, Salem R. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology. 2008 Jan; 47(1):71-81.
    View in: PubMed
    Score: 0.005
  54. Young JY, Rhee TK, Atassi B, Gates VL, Kulik L, Mulcahy MF, Larson AC, Ryu RK, Sato KT, Lewandowski RJ, Omary RA, Salem R. Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol. 2007 Nov; 18(11):1375-82.
    View in: PubMed
    Score: 0.005
  55. Lewandowski RJ, Wang D, Gehl J, Atassi B, Ryu RK, Sato K, Nemcek AA, Miller FH, Mulcahy MF, Kulik L, Larson AC, Salem R, Omary RA. A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring. J Vasc Interv Radiol. 2007 Oct; 18(10):1249-57.
    View in: PubMed
    Score: 0.005
  56. Novak Z, Coldwell DM, Mitchell RD, Ryu RK, Kandarpa K. Percutaneous transgastric placement of esophageal stents. J Vasc Interv Radiol. 1999 Apr; 10(4):428-30.
    View in: PubMed
    Score: 0.003
  57. Chrisman HB, Omary RA, Nemcek AA, Ryu RK, Saker MB, Vogelzang RL. Peripherally inserted central catheters: guidance with use of US versus venography in 2,650 patients. J Vasc Interv Radiol. 1999 Apr; 10(4):473-5.
    View in: PubMed
    Score: 0.003
  58. Biffl WL, Moore EE, Ryu RK, Offner PJ, Novak Z, Coldwell DM, Franciose RJ, Burch JM. The unrecognized epidemic of blunt carotid arterial injuries: early diagnosis improves neurologic outcome. Ann Surg. 1998 Oct; 228(4):462-70.
    View in: PubMed
    Score: 0.003
  59. Tyson LL, Daughters TC, Ryu RK, Crues JV. MRI appearance of meniscal cysts. Skeletal Radiol. 1995 Aug; 24(6):421-4.
    View in: PubMed
    Score: 0.002
  60. Crues JV, Ryu R, Morgan FW. Meniscal pathology. The expanding role of magnetic resonance imaging. Clin Orthop Relat Res. 1990 Mar; (252):80-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)